Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia

Stem Cells

Volumn 17, Issue 4, 1999, Pages 210-218

  Andrews, Robert G ^a,b   Briddell, Robert A ^c   Hill, Robert ^c   Gough, Mike ^d   McNiece, Ian K ^c,e  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c AMGEN INC   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

CD34; Expansion; Hematopoietic progenitors; MGDF; SCF; Transplantation

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT STEM CELL FACTOR;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; APHERESIS; ARTICLE; BABOON; CELL CULTURE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKOCYTE; MEGAKARYOCYTE; NEUTROPENIA; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ANIMALIA; PAPIO; PAPIO HAMADRYAS; PRIMATES;

EID: 0032797772     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.170210     Document Type: Article

References (34)

1. Alcorn MJ, Holyoake TL. Ex vivo expansion of haemopoietic progenitor cells. (Review). Blood Rev 1996;10:167-176.
2. Emerson SG. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 1996;87:3082-3088.
3. Ogawa M, Yonemura Y, Ku H. In vitro expansion of hematopoietic stem cells. Stem Cells 1997;15(suppl 1):7-11.
4. Purdy MH, Hogan CJ, Hami L et al. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. J Hematother 1995;4:515-525.
5. Bhatia M, Bonnet D, Kapp U et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997;186:619-624.
6. Piacibello W, Sanavio F, Garetto L et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2644-2653.
7. DiGiusto DL, Lee R, Moon J et al. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo. Blood 1996;87:1261-1271.
8. + mobilized peripheral blood stem cells. Blood 1998;91:111-117.
9. + progenitor cells. Biol Blood Marrow Transpl 1997;3:133-141.
10. Mielcarek M, Reems J, Torok-Storb B. Extrinsic control of stem cell fate: practical considerations. Stem Cells 1997;15(suppl 1):229-232.
11. Conneally E, Cashman J, Petzer A et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 1997;94:9836-9841.
12. Rosenzweig M, Pykett M, Marks DF et al. Enhanced maintenance and retroviral transduction of primitive hematopoietic progenitor cells using a novel three-dimensional culture system. GeneTher 1997;4:928-936.
13. Yonemura Y, Ku H, Hirayama F et al. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA 1996;93:4040-4044.
14. Miller CL, Eaves CJ. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lymphomyeloid reconstituting ability. Proc Natl Acad Sci USA 1997;94:13648-13653.
15. Holyoake TL, Freshney MG, McNair L et al. Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. Blood 1996;87:4589-4595.
16. Szilvassy SJ, Weller KP, Chen B et al. Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells. Blood 1996;88:3642-3653.
17. Peters SO, Kittler EL, Ramshaw HS et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11 and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996;87:30-37.
18. Traycoff CM, Cornetta K, Yoder MC et al. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Exp Hematol 1996;24:299-306.
19. Yonemura Y, Ku H, Lyman SD et al. In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between FLT3/FLK2 and KIT ligand. Blood 1997;89:1915-1921.
20. Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995;333:283-287.
21. Holyoake TL, Alcorn MJ, Richmond L et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant 1997;19:1095-1101.
22. Alcorn MJ, Holyoake TL, Richmond L et al. CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 1996;14:1839-1847.
23. Bertolini F, Battaglia M, Pedrazzoli P et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 1997;89:2679-2688.
24. + cells in autologous stem cell transplantation for breast cancer. Blood 1996;87:1687-1691.
25. Andrews RG, Bensinger WI, Knitter GH et al. The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 1992;80:2715-2720.
26. Andrews RG, Briddell RA, Knitter GH et al. Rapid engraftment and stable marrow repopulation by peripheral blood progenitor cells mobilized by stem cell factor and granulocyte colony-stimulating factor in nonhuman primates. Blood 1995;85:15-20.
27. Andrews RG, Winkler A, Myerson D et al. Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons. Stem Cells 1996;14:661-677.
28. Broxmeyer HE. Primitive hematopoietic stem and progenitor cells in human umbilical cord blood: an alternative source of transplantable cells. (Review). Cancer Treat Res 1996;84:139-148.
29. Bensinger WI, Longin K, Appelbaum F et al. Peripheral blood stem cells (PBSCs) collected after granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994;87:825-831.
30. + cord blood cells in long-term serum-deprived liquid culture. Blood 1999;93:509-518.
31. Farese AM, Hunt P, Grab LB et al. Combined administration of recombinant human megakaryocyte and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest 1996;97:2145-2151.
32. Harker LA, Marzec UM, Kelly AB et al. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor. Blood 1997;89:155-165.
33. Lansdorp PM, Dragowska W. Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruitment of quiescent progenitors. Exp Hematol 1993;21:1321-1327.
34. Kiem H-P, Heyward S, Winkler A et al. Gene transfer into marrow repopulating cells: comparison between amphotropic and GALV pseudotyped vectors in a competitive repopulation assay in baboons. Blood 1997;90:4638-4645.